Cilcare Updates License Agreement with Sanofi, Brings Pharma Giant on as Equity Holder
The biotech secures improved royalty terms on its two lead hearing loss programs, CIL001 and CIL003, while Sanofi takes a minority stake in the company.
The biotech secures improved royalty terms on its two lead hearing loss programs, CIL001 and CIL003, while Sanofi takes a minority stake in the company.
Sigurd Brandt shares his perspective on what the longevity blind spot survey results mean for audiology and people’s hearing health, now and in the future.
Advanced device features, including those found in new AI-powered hearing aids, can influence overall well-being, not just audibility.
The program, in partnership with 346 hearing care practices, provided hearing aids to 500 individuals across the US and Canada.
If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.
The Rooted & Regulated Retreat will offer mind/body practices and nervous system regulation tools for hearing healthcare professionals.
The collaboration aims to increase hearing health awareness among hunters and shooters and includes a special edition electronic hearing protection product.
The agreement aims to increase access to Natus Sensory’s diagnostic audiology solutions for hearing healthcare practices by leveraging Oaktree’s established network.
The sponsorship anchors the new “Hear to Win” campaign, bringing hearing health education and technology demonstrations to pickleball events nationwide.